Your browser doesn't support javascript.
loading
Impact of visit-to-visit fasting plasma glucose variability on the development of diabetes: The mediation by insulin resistance.
Xu, Jiji; Li, Ling; Huang, Shuangqing; Song, Haihong; Gao, Jinli; Ni, Hengru; Lin, Hong; Wang, Shuangyuan; Li, Mian; Wang, Tiange; Zhao, Zhiyun; Xu, Min; Lu, Jieli; Bi, Yufang; Xu, Yu; Qian, Xiaozhong.
Afiliação
  • Xu J; Songnan Town Community Health Service Center, Shanghai, China.
  • Li L; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Huang S; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong Universi
  • Song H; Department of Pharmacy, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Gao J; Songnan Town Community Health Service Center, Shanghai, China.
  • Ni H; Songnan Town Community Health Service Center, Shanghai, China.
  • Lin H; Songnan Town Community Health Service Center, Shanghai, China.
  • Wang S; Songnan Town Community Health Service Center, Shanghai, China.
  • Li M; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Wang T; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong Universi
  • Zhao Z; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Xu M; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong Universi
  • Lu J; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Bi Y; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong Universi
  • Xu Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Qian X; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong Universi
J Diabetes ; 14(3): 205-215, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35170854

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Diabetes Mellitus / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Diabetes Mellitus / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article